NCT00740935

Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 7,204 (actual)
• Sponsor: University Hospital, Brest · Academic / Other
• Sex: All
• Age: 6 Weeks – 12 Weeks
• Healthy volunteers: Not accepted

Summary

Universal rotavirus vaccination program for infants born in Brest after February 2007, applied by the Centers for Maternal and Infant Health Protection, pediatricians and general practitioners. Prospective surveillance of hospitalizations for gastroenteritis within the Pediatric Units of Brest University Hospital with systematic testing for Rotavirus. Evaluation of the impact of the vaccination program on rotaviral gastroenteritis hospitalizations from 2007-2008 and 2008-2009, by comparison with epidemiological data from 2002-2007 in the absence of vaccination. The principal judgement criterion is the number of pediatric hospitalizations for rotaviral GEA during the 2008-2009 epidemic in children A) under the age of 2 and B) residing in the suburbs of Brest.

Conditions

• Rotavirus Gastroenteritis

Interventions

Type	Name	Description
BIOLOGICAL	Rotateq vaccine	Vaccination against rotavirus Three oral doses (2 mL) between 6 to 26 weeks of life with at least 4 weeks between each dose.

Timeline

• Start date: 2007-05-01
• Primary completion: 2010-12-01
• Completion: 2011-06-01
• First posted: 2008-08-25
• Last updated: 2013-10-22

Locations

1 site across 1 country: France